Skip to Main Content
TRC_PLH
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Diabetes Drugs
    • Do Not Crush List
    • IV Fluid Safety
    • New Drugs
    • Opioid Dosing
    • Vancomycin Dosing
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Hospital Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment

Treatment

  • Angina (18)
  • Antithrombotics (289)
    • Drug-Induced Thrombosis (28)
    • Prevention (44)
    • Reversal (22)
    • Treatment (264)
      • Apixaban (Eliquis) (100)
      • Aspirin (136)
      • Cangrelor (Kengreal) (4)
      • Clopidogrel (Plavix) (80)
      • Dabigatran (Pradaxa) (101)
      • Edoxaban (Savaysa) (41)
      • Low Molecular Weight Heparins (63)
      • Other (40)
      • Prasugrel (Effient) (42)
      • Rivaroxaban (Xarelto) (110)
      • Ticagrelor (Brilinta) (40)
      • Vorapaxar (Zontivity) (1)
      • Warfarin - Drug Interactions (29)
      • Warfarin - Treatment (120)
  • Arrhythmias (131)
  • Blood Pressure (33)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (23)
  • CPR (6)
  • Dyslipidemia (168)
  • Endocarditis (21)
  • Heart Disease (84)
  • Heart Failure (155)
  • Hypertension (225)
  • Hypotension (27)
  • Ischemic Heart Disease/Acute Coronary Syndromes (244)
  • Myocardial Infarction (48)
  • Peripheral Vascular Disease (8)
  • Pulmonary Arterial Hypertension (1)
  • Raynaud's (2)
  • Resources (699)
  • Stroke (119)
46 - 60 of 264 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: Sort Out New VTE Prophylaxis Data in COVID-19 Patients October 2021
Chart: OTC Brand-Name Extensions July 2021
Article: Know the Latest About Antithrombotics in Heart Valve Replacement April 2021
FAQ: Antithrombotics and Valvular Heart Disease: FAQs April 2021
FAQ: Omega-3s: Fish Oil and More January 2021
Article: Answer Common Questions About VTE Treatment December 2020
Chart: Pulmonary Embolism: Focus on Thrombolytics December 2020
Article: Plan Your Strategy to Reverse Warfarin or DOAC Bleeds September 2020
Algorithm: How to Manage High INRs in Warfarin Patients September 2020
Article: Weigh VTE Prevention Strategies in COVID-19 August 2020
Chart: LMWH Dosing in Special Populations July 2020
Article: Be Prepared to Treat and Prevent VTE Due to Cancer June 2020
Chart: P-glycoprotein Drug Interactions June 2020
Article: Be Prepared to Manage Direct Oral Anticoagulants Around Surgery October 2019
Article: Maximize Safety When Using Anticoagulants in Patients With Cirrhosis July 2019
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved